SHP-1 was found to dephosphorylate CagA and thus mitigate its oncogenic potential while EBV infection leads to the SHP-1 down-regulation via promoter DNA methylation, which augments the oncogenic activities of H. pylori [105]. Here, S100A8 is linked to Epstein-Barr virus infection.